LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 24

Search options

  1. Article ; Online: Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.

    Di Ianni, Mauro / Liberatore, Carmine / Santoro, Nicole / Ranalli, Paola / Guardalupi, Francesco / Corradi, Giulia / Villanova, Ida / Di Francesco, Barbara / Lattanzio, Stefano / Passeri, Cecilia / Lanuti, Paola / Accorsi, Patrizia

    Cells

    2024  Volume 13, Issue 2

    Abstract: GvHD still remains, despite the continuous improvement of transplantation platforms, a fearful complication of transplantation from allogeneic donors. Being able to separate GvHD from GvL represents the greatest challenge in the allogeneic transplant ... ...

    Abstract GvHD still remains, despite the continuous improvement of transplantation platforms, a fearful complication of transplantation from allogeneic donors. Being able to separate GvHD from GvL represents the greatest challenge in the allogeneic transplant setting. This may be possible through continuous improvement of cell therapy techniques. In this review, current cell therapies are taken into consideration, which are based on the use of TCR alpha/beta depletion, CD45RA depletion, T regulatory cell enrichment, NK-cell-based immunotherapies, and suicide gene therapies in order to prevent GvHD and maximally amplify the GvL effect in the setting of haploidentical transplantation.
    MeSH term(s) Humans ; Transplantation, Haploidentical ; Cell- and Tissue-Based Therapy ; Fear ; Immunotherapy ; Killer Cells, Natural
    Language English
    Publishing date 2024-01-11
    Publishing country Switzerland
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells13020134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Study of pulsed electrostatic field (PESF) in the perfusion of peripheral tissues: Microangiopathy, nutrition and quality of perceiver life.

    Liani, Rossella / La Torre, Sara / Liani, Valentina / Melchiorre, Angela / D'Ettorre, Danilo / Tripaldi, Romina / Lattanzio, Stefano / Di Luzio, Rossano / Coli, Mauro / Velussi, Carlo

    PloS one

    2022  Volume 17, Issue 9, Page(s) e0268497

    Abstract: Microangiopathy compromises the structural and functional integrity of organs and tissues in patients with type II diabetes mellitus (T2DM) negatively affecting the perceived quality of life. Nitric oxide (NO) is a multifunctional signalling molecule, ... ...

    Abstract Microangiopathy compromises the structural and functional integrity of organs and tissues in patients with type II diabetes mellitus (T2DM) negatively affecting the perceived quality of life. Nitric oxide (NO) is a multifunctional signalling molecule, acting as a vasodilator, neurotransmitter, and modulator of inflammatory processes. Patients with type II diabetes mellitus and chronic kidney disease, controlled from glycaemic status, were treated or not with pulsed electrostatic field (PESF) cycles to evaluate effect on the perfusion of peripheral tissues. Everyone was monitored for the metabolic profile, and we tested circulating NO with a commercial enzyme immunoassay kit. In addition, we tested the perceived quality of life of patients before/after a PESF cycle using a questionnaire. Patients treated with PESF were improved circulating NO levels, significant changes in systolic and diastolic blood pressure, heart rate and were more homogeneous for their metabolic profile. The questionnaire showed also a marked improvement in the perceived quality of life. The use of pulsed electrostatic fields has allowed us to observe an improvement in the metabolic, psychological, and clinical profile in patients with T2DM and chronic kidney disease whose pathological profile is strongly compromised.
    MeSH term(s) Diabetes Mellitus, Type 2 ; Humans ; Nitric Oxide ; Perfusion ; Quality of Life ; Renal Insufficiency, Chronic/therapy ; Static Electricity ; Vascular Diseases ; Vasodilator Agents
    Chemical Substances Vasodilator Agents ; Nitric Oxide (31C4KY9ESH)
    Language English
    Publishing date 2022-09-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0268497
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Ultrarush venom immunotherapy and the lipoxin a4 inflammation resolution pathway.

    Gangemi, Sebastiano / Patella, Vincenzo / Cianci, Eleonora / Saitta, Salvatore / Lattanzio, Stefano / Florio, Giovanni / Romano, Mario

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

    2012  Volume 109, Issue 3, Page(s) 226–227

    MeSH term(s) Adult ; Animals ; Arthropod Venoms/administration & dosage ; Arthropod Venoms/immunology ; Bee Venoms/administration & dosage ; Bee Venoms/immunology ; Desensitization, Immunologic/adverse effects ; Desensitization, Immunologic/methods ; Female ; Humans ; Hymenoptera/immunology ; Hypersensitivity, Immediate/drug therapy ; Inflammation/etiology ; Inflammation/immunology ; Lipoxins/immunology ; Lipoxins/urine ; Male ; Middle Aged
    Chemical Substances Arthropod Venoms ; Bee Venoms ; Lipoxins ; lipoxin A4
    Language English
    Publishing date 2012-09
    Publishing country United States
    Document type Letter
    ZDB-ID 1228189-x
    ISSN 1534-4436 ; 0003-4738 ; 1081-1206
    ISSN (online) 1534-4436
    ISSN 0003-4738 ; 1081-1206
    DOI 10.1016/j.anai.2012.07.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Pentraxin 3 and Platelet Activation in Obese Patients After Gastric Banding.

    Santilli, Francesca / Guagnano, Maria Teresa / Innocenti, Paolo / Aceto, Liberato / Vazzana, Natale / Lattanzio, Stefano / Liani, Rossella / Tripaldi, Romina / Creato, Valeria / Romano, Mario / Davì, Giovanni

    Circulation journal : official journal of the Japanese Circulation Society

    2016  Volume 80, Issue 2, Page(s) 502–511

    Abstract: Background: Circulating pentraxin 3 (PTX3), the main regulator of the inflammatory response, rapidly increases following cardiovascular events, and low PTX3 is associated with high body mass index.: Methods and results: We conducted a 12-month ... ...

    Abstract Background: Circulating pentraxin 3 (PTX3), the main regulator of the inflammatory response, rapidly increases following cardiovascular events, and low PTX3 is associated with high body mass index.
    Methods and results: We conducted a 12-month longitudinal study, to test the hypothesis that laparoscopic adjustable gastric banding (LAGB)-induced weight loss was associated with changes in platelet activation markers and PTX3. Twelve obese patients, scheduled to undergo LAGB, were enrolled at the University Obesity Center. Urinary 11-dehydro-thromboxane (Tx)B2excretion rate was measured on radioimmunoassay, and PTX3 and CD40L were determined on immunoassay. Plasma PTX3 increased by 178.8 and 214.9% (P<0.0001), respectively, 6 and 12 months after LAGB. High-sensitivity CRP decreased by 24 and 29.7% (P<0.0001), whereas CD40L decreased by 64.3 and 58.6% (P=0.002), respectively. Urinary 11-dehydro-TxB2decreased from 1,443 to 715 and 564 pg/mg creatinine, respectively 6 months and 12 months after LAGB (P<0.0001). PTX3 was inversely related to platelet activation markers, 11-dehydro-TxB2and CD40L. Moreover, multiple regression analysis on pooled data showed that plasma PTX3 was an independent predictor of urinary 11-dehydro-TxB2.
    Conclusions: There is an association between inflammation, platelet activation and metabolic dysfunction in obesity, and PTX3 is a key player within these circuits.
    MeSH term(s) Adult ; C-Reactive Protein/metabolism ; CD40 Ligand/blood ; Female ; Follow-Up Studies ; Gastric Bypass ; Humans ; Male ; Middle Aged ; Obesity/blood ; Obesity/surgery ; Obesity/urine ; Platelet Activation ; Serum Amyloid P-Component/metabolism ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine
    Chemical Substances Serum Amyloid P-Component ; CD40 Ligand (147205-72-9) ; PTX3 protein (148591-49-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2016
    Publishing country Japan
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2068090-9
    ISSN 1347-4820 ; 1346-9843
    ISSN (online) 1347-4820
    ISSN 1346-9843
    DOI 10.1253/circj.CJ-15-0721
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.

    Vazzana, Natale / Santilli, Francesca / Lattanzio, Stefano / Liani, Mario / Giacci, Luciano / Del Rosso, Goffredo / Salvati, Filippo / Boccatonda, Andrea / Ferroni, Patrizia / Davì, Giovanni

    European journal of internal medicine

    2016  Volume 33, Page(s) 74–80

    Abstract: Background: Mechanisms of accelerated atherothrombosis in patients with chronic kidney disease (CKD) are only partly characterized. The aims of this study were to evaluate the extent of thromboxane (TX)-dependent platelet activation in patients with CKD, ...

    Abstract Background: Mechanisms of accelerated atherothrombosis in patients with chronic kidney disease (CKD) are only partly characterized. The aims of this study were to evaluate the extent of thromboxane (TX)-dependent platelet activation in patients with CKD, and to characterize the determinants of altered TX biosynthesis in this setting, with particular reference to enhanced lipid peroxidation, low grade inflammation and CKD-related anemia.
    Patients and methods: A cross sectional comparison between urinary 8-iso-PGF2α and 11-dehydro-TXB2, in vivo markers of oxidative stress and platelet activation, respectively, was performed in 115 patients with stage 1-4 CKD.
    Results: Levels of both urinary 11-dehydro-TXB2 and 8-iso-PGF2α increased sequentially across the four CKD stages (P<0.0001, Kruskal-Wallis test). Both urinary prostanoids were inversely associated with either estimated glomerular filtration rate (eGFR, P<0.0001) or hemoglobin levels (P<0.0001). A significant direct correlation was also observed between urinary 11-dehydro-TXB2 and 8-iso-PGF2α (Rho=0.620, P<0.0001). On multivariate analysis, urinary 8-iso-PGF2α (β=0.459, P<0.0001), hemoglobin levels (β=- 0.261, P=0.002) and eGFR (β=-0.172, P=0.032) were independent predictors of urinary 11-dehydro-TXB2 (adjusted R(2)=0.488).
    Conclusions: This study provides biochemical evidence of persistent platelet activation in patients with CKD. This condition occurs early in the natural history of the disease and is related to kidney function and oxidative stress. Moreover, we found an independent inverse relationship between hemoglobin levels and TX-dependent platelet activation. This finding may provide a mechanistic link between CKD-related anemia and increased cardiovascular risk.
    MeSH term(s) Aged ; Biomarkers/urine ; Cardiovascular Diseases/epidemiology ; Cross-Sectional Studies ; Dinoprost/analogs & derivatives ; Dinoprost/urine ; Erythropoietin/blood ; Female ; Glomerular Filtration Rate ; Hemoglobins/analysis ; Humans ; Italy ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Oxidative Stress ; Platelet Activation ; Prostaglandins/biosynthesis ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/urine ; Risk Assessment ; Risk Factors ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine
    Chemical Substances Biomarkers ; Hemoglobins ; Prostaglandins ; Erythropoietin (11096-26-7) ; 8-epi-prostaglandin F2alpha (27415-26-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; Dinoprost (B7IN85G1HY)
    Language English
    Publishing date 2016-09
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2016.06.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.

    Vazzana, Natale / Guagnano, Maria Teresa / Cuccurullo, Chiara / Ferrante, Elisabetta / Lattanzio, Stefano / Liani, Rossella / Romano, Mario / Davì, Giovanni

    The Journal of clinical endocrinology and metabolism

    2012  Volume 97, Issue 9, Page(s) E1726–30

    Abstract: Context: The receptor for advanced glycation end-products (RAGE) has been implicated in obesity-related metabolic disease and accelerated atherothrombosis.: Objective: We tested the hypothesis that changes in endogenous secretory (es)RAGE levels as a ...

    Abstract Context: The receptor for advanced glycation end-products (RAGE) has been implicated in obesity-related metabolic disease and accelerated atherothrombosis.
    Objective: We tested the hypothesis that changes in endogenous secretory (es)RAGE levels as a result of excess adiposity and oxidative stress may contribute to enhancing platelet activation in obese women, thus increasing the cardiovascular risk.
    Patients: Eighty otherwise healthy obese women and 20 nonobese women were studied.
    Results: esRAGE and plasma adiponectin were reduced in obese women [median (interquartile range), 0.18 (0.13-0.26) vs. 0.38 (0.20-0.48) ng/ml, P = 0.003; and 4.4 (2.8-6.4) vs. 10.0 (6.9-12.5) μg/ml, P < 0.0001, respectively] who also displayed higher urinary 11-dehydro-thromboxane B(2) (11-dehydro-TXB(2)) [795 (572-1089) vs. 211 (135-301) pg/mg creatinine; P < 0.0001] and 8-iso-prostaglandin F(2α) (8-iso-PGF(2α)) [544 (402-698) vs. 149 (98-219) pg/mg creatinine; P < 0.0001] compared to nonobese women. Direct correlations between plasma adiponectin and esRAGE (Rho = 0.43; P < 0.0001) and between urinary 8-iso-PGF(2α) and 11-dehydro-TXB(2) (Rho = 0.36; P = 0.001) were observed in obese women. Moreover, plasma esRAGE and urinary 11-dehdro-TXB(2) were inversely related (Rho = -0.29; P = 0.008). On multiple linear regression analysis, urinary 8-iso-PGF(2α) and plasma esRAGE were independent predictors of urinary 11-dehydro-TXB(2). In five obese women, a short-term weight loss program gave a significant increase in esRAGE and decrease in urinary 8-iso-PGF(2α) and 11-dehydro-TXB(2).
    Conclusion: In otherwise healthy obese women, low plasma esRAGE levels are associated with reduced circulating adiponectin and enhanced thromboxane biosynthesis, which is in part mediated by increased lipid peroxidation. Thus, excess adiposity may be implicated in RAGE hyperactivation and thromboxane-dependent platelet activation, contributing to obesity-related metabolic and vascular disease.
    MeSH term(s) Adiponectin/blood ; Adult ; Anthropometry ; Blood Glucose/metabolism ; Blood Pressure/physiology ; Cardiovascular Diseases/epidemiology ; Dinoprost/analogs & derivatives ; Dinoprost/urine ; Female ; Humans ; Linear Models ; Lipid Peroxidation/physiology ; Lipids/blood ; Middle Aged ; Obesity/blood ; Obesity/metabolism ; Oxidative Stress/physiology ; Platelet Activation/physiology ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic/blood ; Receptors, Immunologic/metabolism ; Risk ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine ; Weight Loss/physiology
    Chemical Substances Adiponectin ; Blood Glucose ; Lipids ; Receptor for Advanced Glycation End Products ; Receptors, Immunologic ; 8-epi-prostaglandin F2alpha (27415-26-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; Dinoprost (B7IN85G1HY)
    Language English
    Publishing date 2012-09
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3029-6
    ISSN 1945-7197 ; 0021-972X
    ISSN (online) 1945-7197
    ISSN 0021-972X
    DOI 10.1210/jc.2012-1473
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.

    Dragani, Alfredo / Falco, Angela / Santilli, Francesca / Basili, Stefania / Rolandi, Giancarlo / Cerasa, Loredana / Lattanzio, Stefano / Ciabattoni, Giovanni / Patrono, Carlo / Davì, Giovanni

    Thrombosis and haemostasis

    2012  Volume 108, Issue 3, Page(s) 533–542

    Abstract: The methylenetetrahydrofolate reductase (MTHFR) 677 C→T polymorphism may be associated with elevated total homocysteine (tHcy) levels, an independent risk factor for cardiovascular disease. It was the study objective to evaluate in vivo lipid ... ...

    Abstract The methylenetetrahydrofolate reductase (MTHFR) 677 C→T polymorphism may be associated with elevated total homocysteine (tHcy) levels, an independent risk factor for cardiovascular disease. It was the study objective to evaluate in vivo lipid peroxidation and platelet activation in carriers of the MTHFR 677 C→T polymorphism and in non-carriers, in relation to tHcy and folate levels. A cross-sectional comparison of urinary 8-iso-prostaglandin (PG)F(2α) and 11-dehydro-thromboxane (TX)B(2) (markers of in vivo lipid peroxidation and platelet activation, respectively) was performed in 100 carriers and 100 non-carriers of the polymorphism. A methionine-loading test and folic acid supplementation were performed to investigate the causal relationship of the observed associations. Urinary 8-iso-PGF(2α) and 11-dehydro-TXB(2) were higher in carriers with hyperhomocysteinaemia than in those without hyperhomocysteinaemia (p<0.0001). Hyperhomocysteinaemic carriers had lower folate levels (p=0.0006), higher urinary 8-iso-PGF(2α) (p<0.0001) and 11-dehydro-TXB(2) (p<0.0001) than hyperhomocysteinaemic non-carriers. On multiple regression analysis, high tHcy (p<0.0001), low folate (p<0.04) and MTHFR 677 C→T polymorphism (p<0.001) independently predicted high rates of 8-iso-PGF(2α) excretion. Methionine loading increased plasma tHcy (p=0.002), and both urinary prostanoid metabolites (p=0.002). Folic acid supplementation was associated with decreased urinary 8-iso-PGF(2α) and 11-dehydro-TXB2 excretion (p<0.0003) in the hyperhomocysteinaemic group, but not in the control group, with substantial inter-individual variability related to baseline tHcy level and the extent of its reduction. In conclusion, hyperhomocysteinaemia due to the MTHFR 677 C→T polymorphism is associated with enhanced in vivo lipid peroxidation and platelet activation that are reversible, at least in part, following folic acid supplementation. An integrated biomarker approach may help identifying appropriate candidates for effective folate supplementation.
    MeSH term(s) Biomarkers ; Cardiovascular Diseases/epidemiology ; Comorbidity ; Cross-Sectional Studies ; Diabetes Mellitus/epidemiology ; Dinoprost/analogs & derivatives ; Dinoprost/urine ; Dyslipidemias/epidemiology ; Folic Acid/blood ; Folic Acid/therapeutic use ; Homocystinuria/blood ; Homocystinuria/epidemiology ; Homocystinuria/genetics ; Humans ; Hyperhomocysteinemia/blood ; Hyperhomocysteinemia/drug therapy ; Hyperhomocysteinemia/epidemiology ; Hyperhomocysteinemia/genetics ; Lipid Peroxidation ; Methionine ; Methylenetetrahydrofolate Reductase (NADPH2)/blood ; Methylenetetrahydrofolate Reductase (NADPH2)/deficiency ; Methylenetetrahydrofolate Reductase (NADPH2)/genetics ; Muscle Spasticity/blood ; Muscle Spasticity/epidemiology ; Muscle Spasticity/genetics ; Oxidative Stress ; Platelet Activation ; Polymorphism, Single Nucleotide ; Psychotic Disorders/blood ; Psychotic Disorders/epidemiology ; Psychotic Disorders/genetics ; Smoking/epidemiology ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine
    Chemical Substances Biomarkers ; 8-epi-prostaglandin F2alpha (27415-26-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; Folic Acid (935E97BOY8) ; Methionine (AE28F7PNPL) ; Dinoprost (B7IN85G1HY) ; Methylenetetrahydrofolate Reductase (NADPH2) (EC 1.5.1.20)
    Language English
    Publishing date 2012-09
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 518294-3
    ISSN 0340-6245
    ISSN 0340-6245
    DOI 10.1160/TH11-12-0899
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects.

    Simeoni, Simona / Biselli, Roberto / D'Amelio, Raffaele / Rocca, Bianca / Lattanzio, Stefano / Mucci, Luciana / Davì, Giovanni / Patacchioli, Francesca Romana

    Stress (Amsterdam, Netherlands)

    2011  Volume 14, Issue 3, Page(s) 282–289

    Abstract: Few studies have assessed the effects of stress on in vivo platelet activation. In the present study, hypobaric hypoxia induced by rapid decompression during high-altitude simulated flight in a hypobaric chamber was used to evaluate the effects of ... ...

    Abstract Few studies have assessed the effects of stress on in vivo platelet activation. In the present study, hypobaric hypoxia induced by rapid decompression during high-altitude simulated flight in a hypobaric chamber was used to evaluate the effects of environmental stress on salivary cortisol and urinary thromboxane metabolite (TXM) excretion, a noninvasive marker of in vivo platelet function. Twenty-one male aviators (mean ± SD age = 36 ± 7 years) experiencing hypoxia by removing their oxygen mask for 4-5 min during a simulated flight to 25,000 ft (7,620 m; pO(2) = 59.17 mmHg) and a matched control group of thirteen flying instructors wearing oxygen masks during the challenge, were studied. Hypobaric hypoxia induced a transient significant increase (P < 0.001) in the aviators' salivary cortisol concentration; the overall pattern of diurnal cortisol fluctuation was maintained in both groups. Urinary TXM showed a significant ∼30% reduction (P < 0.01) after the chamber session in aviators exposed to hypobaric hypoxia, but not in controls. A significant inverse correlation was found between salivary cortisol and urinary TXM in aviators (r = - 0.64, P = 0.0015). Salivary cortisol was a significant predictor (P < 0.001) for urinary TXM concentrations in aviators. In conclusion, here we observed that an acute stress-induced salivary cortisol increase was associated with reduced urinary thromboxane biosynthesis, providing the first indirect evidence for an inhibitory effect of acute stress on in vivo platelet function.
    MeSH term(s) Adult ; Altitude Sickness/physiopathology ; Dinoprost/analogs & derivatives ; Dinoprost/urine ; Humans ; Hydrocortisone/secretion ; Hypoxia/physiopathology ; Male ; Saliva/chemistry ; Stress, Physiological/physiology ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine
    Chemical Substances 8-epi-prostaglandin F2alpha (27415-26-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; Dinoprost (B7IN85G1HY) ; Hydrocortisone (WI4X0X7BPJ)
    Language English
    Publishing date 2011-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1387706-9
    ISSN 1607-8888 ; 1025-3890
    ISSN (online) 1607-8888
    ISSN 1025-3890
    DOI 10.3109/10253890.2010.545458
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia

    Puccetti, Luca / Santilli, Francesca / Pasqui, Anna Laura / Lattanzio, Stefano / Liani, Rossella / Ciani, Federica / Ferrante, Elisabetta / Ciabattoni, Giovanni / Scarpini, Francesca / Ghezzi, Anna / Auteri, Alberto / Davì, Giovanni

    Atherosclerosis. 2011 Jan., v. 214, no. 1

    2011  

    Abstract: OBJECTIVES: We examined the time-dependent effects of atorvastatin and rosuvastatin on in vivo oxidative stress and platelet activation, to assess whether these phenomena are related to any pleiotropic effect of any statin or to their LDL-lowering effect. ...

    Abstract OBJECTIVES: We examined the time-dependent effects of atorvastatin and rosuvastatin on in vivo oxidative stress and platelet activation, to assess whether these phenomena are related to any pleiotropic effect of any statin or to their LDL-lowering effect. We also asked whether the presence of specific allele frequencies in carriers of the 3′UTR/lectin-like oxidized LDL receptor-1 (LOX-1) polymorphism may influence the effect of either statin. METHODS: We included 60 hypercholesterolemic subjects, previously screened for LOX-1 3′UTR polymorphism, randomized, according to genetic profile (15 T and 15 C carriers for each arm), to atorvastatin 20mg/day or rosuvastatin 10mg/day. RESULTS: After 8 weeks, atorvastatin and rosuvastatin were associated with comparable, significant reductions in LDL cholesterol (40.8% and 43.6%, respectively), plasma hs-CRP (9.5% vs. 13.8%), urinary 11-dehydro-thromboxane (TX) B₂ (38.9% vs. 27.1%) and 8-iso-prostaglandin (PG) F₂α (39.4% vs. 19.4%). The impact of rosuvastatin or atorvastatin on CRP, 8-iso-PGF₂α, and 11-dehydro-TXB₂ did not differ according to the LOX-1 haplotype. On multiple regression analyses, only CRP and LDL were independent predictors of 11-dehydro-TXB₂, and only LDL was a significant predictor of 8-iso-PGF₂α. CONCLUSIONS: Both atorvastatin and rosuvastatin cause comparable reductions of thromboxane-dependent platelet activation, lipid peroxidation and inflammation. The presence of 3′UTR/LOX-1 polymorphism does not affect the changes induced by either statin.
    Keywords atherosclerosis ; gene frequency ; haplotypes ; hypercholesterolemia ; inflammation ; lipid peroxidation ; low density lipoprotein cholesterol ; oxidative stress ; platelet activation ; regression analysis
    Language English
    Dates of publication 2011-01
    Size p. 122-128.
    Publishing place Elsevier Ireland Ltd
    Document type Article
    ZDB-ID 80061-2
    ISSN 1879-1484 ; 0021-9150
    ISSN (online) 1879-1484
    ISSN 0021-9150
    DOI 10.1016/j.atherosclerosis.2010.10.006
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.

    Santilli, Francesca / Paloscia, Leonardo / Liani, Rossella / Di Nicola, Marta / Di Marco, Massimo / Lattanzio, Stefano / La Barba, Sara / Pascale, Silvia / Mascellanti, Marco / Davì, Giovanni

    Journal of the American Heart Association

    2014  Volume 3, Issue 4

    Abstract: Background: Platelet activation is involved in acute coronary syndromes (ACS). Incomplete suppression by low-dose aspirin treatment of thromboxane (TX) metabolite excretion (urinary 11-dehydro-TXB2) is predictive of vascular events in high-risk patients. ...

    Abstract Background: Platelet activation is involved in acute coronary syndromes (ACS). Incomplete suppression by low-dose aspirin treatment of thromboxane (TX) metabolite excretion (urinary 11-dehydro-TXB2) is predictive of vascular events in high-risk patients. Myeloid-related protein (MRP)-8/14 is a heterodimer secreted on activation of platelets, monocytes, and neutrophils, regulating inflammation and predicting cardiovascular events. Among platelet transcripts, MRP-14 has emerged as a powerful predictor of ACS.
    Methods and results: We enrolled 68 stable ischemic heart disease (IHD) and 63 ACS patients, undergoing coronary angiography, to evaluate whether MRP-8/14 release in the circulation is related to TX-dependent platelet activation in ACS and IHD patients and to residual TX biosynthesis in low-dose aspirin-treated ACS patients. In ACS patients, plasma MRP-8/14 and urinary 11-dehydro-TXB2 levels were linearly correlated (r=0.651, P<0.001) but significantly higher than those in IHD patients (P=0.012, P=0.044) only among subjects not receiving aspirin. In aspirin-treated ACS patients, MRP-8/14 and 11-dehydro-TXB2 were lower versus those not receiving aspirin (P<0.001) and still significantly correlated (r=0.528, P<0.001). Higher 11-dehydro-TXB2 significantly predicted higher MRP-8/14 in both all ACS patients and ACS receiving aspirin (P<0.001, adj R(2)=0.463 and adj R(2)=0.497) after multivariable adjustment. Conversely, plasma MRP-8/14 (P<0.001) and higher urinary 8-iso-prostaglandin F2α (P=0.050) levels were significant predictors of residual, on-aspirin, TX biosynthesis in ACS (adjusted R(2)=0.384).
    Conclusions: Circulating MRP-8/14 is associated with TX-dependent platelet activation in ACS, even during low-dose aspirin treatment, suggesting a contribution of residual TX to MRP-8/14 shedding, which may further amplify platelet activation. Circulating MRP-8/14 may be a target to test different antiplatelet strategies in ACS.
    MeSH term(s) Acute Coronary Syndrome/blood ; Acute Coronary Syndrome/drug therapy ; Aged ; Aspirin/therapeutic use ; Calgranulin A/blood ; Calgranulin B/blood ; Chronic Disease ; Dinoprost/analogs & derivatives ; Dinoprost/urine ; Female ; Humans ; Male ; Middle Aged ; Myocardial Ischemia/blood ; Myocardial Ischemia/drug therapy ; Platelet Activation ; Platelet Aggregation Inhibitors/therapeutic use ; Thromboxane B2/analogs & derivatives ; Thromboxane B2/urine
    Chemical Substances Calgranulin A ; Calgranulin B ; Platelet Aggregation Inhibitors ; 8-epi-prostaglandin F2alpha (27415-26-5) ; Thromboxane B2 (54397-85-2) ; 11-dehydro-thromboxane B2 (67910-12-7) ; Dinoprost (B7IN85G1HY) ; Aspirin (R16CO5Y76E)
    Language English
    Publishing date 2014-07-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2653953-6
    ISSN 2047-9980 ; 2047-9980
    ISSN (online) 2047-9980
    ISSN 2047-9980
    DOI 10.1161/JAHA.114.000903
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top